GLPwatch

[Therapeutic use and adverse events of incretin-related drugs].

Nihon Rinsho · 2012

Last updated 2026-05-28
JournalNihon Rinsho, 2012
Citations0
Relative citation ratio0.00
NIH percentile0
Molecules
Conditions studied Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease, Mash, Heart Failure

Full record and abstract on PubMed 22768601 ↗